AI VIVO

📍 Cambridge, United Kingdom👥 5 employees💰 Last funded 2019
AI VIVO is a Cambridge (UK) based company with a unique systems pharmacology platform powered by AI to accelerate drug discovery. We believe biology, health and disease are all about balance and imbalance. Our platform provide a proprietary system-driven methodology to represent these imbalances using functional omics data and predict unexpected novel modulation strategies to restore the stability and alleviating pathological imbalance. This disruptive technology enables us to speed up the whole drug discovery process by identify promising candidates, de-risk the opportunities through preclinical validations, and progress drug candidates to the clinic through industry and investor partnerships.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in AI VIVO?
AI VIVO has 1 investors on record on gritt.io.
When did AI VIVO last raise funding?
The most recent investment in AI VIVO recorded on gritt.io was in 2019.
What industry is AI VIVO in?
AI VIVO operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is AI VIVO based?
AI VIVO is headquartered in Cambridge, United Kingdom.